Capital International Investors Novo Cure LTD Transaction History
Capital International Investors
- $504 Billion
- Q3 2024
A detailed history of Capital International Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital International Investors holds 7,922,761 shares of NVCR stock, worth $128 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,922,761
Previous 11,696,348
32.26%
Holding current value
$128 Million
Previous $200 Million
38.19%
% of portfolio
0.02%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$195 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$191 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$69.4 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$48.8 Million12.67% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$45.2 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.69B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...